CXCR3-activating peptide inhibits pulmonary fibrosis in a bleomycin mouse model
Abstract Abnormal wound healing and dysregulated inflammation in the lung results in scarring and progressive fibrosis, which are hallmarks of Idiopathic Pulmonary Fibrosis (IPF) and post-COVID injury-related lung fibrosis. Chemokine signaling through the CXCR3 receptor and the CXCR3-activating chem...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-10-01
|
| Edice: | Respiratory Research |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12931-025-03384-6 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
